{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:36:16Z","timestamp":1783784176211,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203134"],"award-info":[{"award-number":["82203134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"grants from Jiangsu province","award":["BZ2022058"],"award-info":[{"award-number":["BZ2022058"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15792-y","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:04:22Z","timestamp":1772003062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of nuclear import suppresses androgen receptor action and overcomes resistance in prostate cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Xuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"2","key":"15792_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.21037\/tcr-23-1680","volume":"13","author":"Z Ke","year":"2024","unstructured":"Ke Z, Xu Y, Shu Y, Wang C, Wu B, Zhang B, et al. Multivariate logistic regression analysis of the clinical factors influencing locally advanced prostate cancer. Transl Cancer Res. 2024;13(2):676\u201385.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"15792_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s12951-024-03070-7","volume":"22","author":"B Deng","year":"2024","unstructured":"Deng B, Ke B, Tian Q, Gao Y, Zhai Q, Zhang W. Targeting AURKA with multifunctional nanoparticles in CRPC therapy. J Nanobiotechnol. 2024;22(1):803.","journal-title":"J Nanobiotechnol"},{"key":"15792_CR3","doi-asserted-by":"publisher","first-page":"1129140","DOI":"10.3389\/fonc.2023.1129140","volume":"13","author":"KJ Miller","year":"2023","unstructured":"Miller KJ, Henry I, Maylin Z, Smith C, Arunachalam E, Pandha H, et al. A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer. Front Oncol. 2023;13:1129140.","journal-title":"Front Oncol"},{"issue":"2","key":"15792_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/bph.15300","volume":"178","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, et al. Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021;178(2):239\u201361.","journal-title":"Br J Pharmacol"},{"key":"15792_CR5","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1016\/j.csbj.2023.10.044","volume":"21","author":"X Ma","year":"2023","unstructured":"Ma X, Chen L, Chen T, Chen K, Zhang H, Huang K, et al. Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer. Comput Struct Biotechnol J. 2023;21:5476\u201390.","journal-title":"Comput Struct Biotechnol J"},{"issue":"21","key":"15792_CR6","doi-asserted-by":"publisher","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","volume":"17","author":"M Xu","year":"2023","unstructured":"Xu M, Qi Y, Liu G, Song Y, Jiang X, Du B. Size-Dependent In Vivo Transport of Nanoparticles: Implications for Delivery, Targeting, and Clearance. ACS Nano. 2023;17(21):20825\u201349.","journal-title":"ACS Nano"},{"issue":"8","key":"15792_CR7","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1021\/acs.nanolett.2c00667","volume":"22","author":"H Li","year":"2022","unstructured":"Li H, Ho LWC, Lee LKC, Liu S, Chan CKW, Tian XY, et al. Intranuclear Delivery of DNA Nanostructures via Cellular Mechanotransduction. Nano Lett. 2022;22(8):3400\u20139.","journal-title":"Nano Lett"},{"issue":"11","key":"15792_CR8","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1038\/s41418-021-00801-3","volume":"28","author":"S Dasgupta","year":"2021","unstructured":"Dasgupta S, Ghosh T, Dhar J, Bhuniya A, Nandi P, Das A, et al. RGS5\u2013TGF\u03b2\u2013Smad2\/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth. Cell Death Differ. 2021;28(11):3052\u201376.","journal-title":"Cell Death Differ"},{"issue":"24","key":"15792_CR9","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1128\/MCB.00647-13","volume":"33","author":"L Ni","year":"2013","unstructured":"Ni L, Llewellyn R, Kesler CT, Kelley JB, Spencer A, Snow CJ, et al. Androgen Induces a Switch from Cytoplasmic Retention to Nuclear Import of the Androgen Receptor. Mol Cell Biol. 2013;33(24):4766\u201378.","journal-title":"Mol Cell Biol"},{"issue":"10","key":"15792_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/biomedicines8100422","volume":"8","author":"EA Messner","year":"2020","unstructured":"Messner EA, Steele TM, Tsamouri MM, Hejazi N, Gao AC, Mudryj M, et al. The androgen receptor in prostate cancer: Effect of structure, ligands and spliced variants on therapy. Biomedicines. 2020;8(10):422.","journal-title":"Biomedicines"},{"issue":"9","key":"15792_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1158\/2159-8290.CD-13-0226","volume":"3","author":"JD Joseph","year":"2013","unstructured":"Joseph JD, Lu N, Qian J, Sensintaffar J, Shao G, Brigham D, et al. A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509. Cancer Discov. 2013;3(9):1020\u20139.","journal-title":"Cancer Discov"},{"issue":"6","key":"15792_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00418-022-02134-9","volume":"158","author":"Y He","year":"2022","unstructured":"He Y, Li J, Peng L, Li Q, Chu Y, Lin Q, et al. Effects of Ran-GTP\/importin \u03b2 inhibition on the meiotic division of porcine oocytes. Histochem Cell Biol. 2022;158(6):571\u201382.","journal-title":"Histochem Cell Biol"},{"key":"15792_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s42003-018-0105-8","volume":"1","author":"J Salami","year":"2018","unstructured":"Salami J, Alabi S, Willard RR, Vitale NJ, Wang J, Dong H, et al. Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance. Commun Biol. 2018;1:100.","journal-title":"Commun Biol"},{"key":"15792_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fonc.2018.00180","volume":"8","author":"A Ark","year":"2018","unstructured":"Ark A, Vander, Cao J, Li X. Mechanisms and approaches for overcoming enzalutamide resistance in prostate cancer. Front Oncol. 2018;8:180.","journal-title":"Front Oncol"},{"issue":"3","key":"15792_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/pcan.2016.17","volume":"19","author":"ES Antonarakis","year":"2016","unstructured":"Antonarakis ES, Armstrong AJ, Dehm SM, Luo J. Androgen receptor variant-driven prostate cancer: Clinical implications and therapeutic targeting. Prostate Cancer Prostatic Dis. 2016;19(3):231\u201341.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"15792_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1172\/JCI122819","volume":"129","author":"A Sharp","year":"2019","unstructured":"Sharp A, Coleman I, Yuan W, Sprenger C, Dolling D, Rodrigues DN, et al. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer. J Clin Invest. 2019;129(1):192\u2013208.","journal-title":"J Clin Invest"},{"issue":"3","key":"15792_CR17","doi-asserted-by":"publisher","first-page":"288","DOI":"10.5534\/wjmh.180040","volume":"37","author":"K Fujita","year":"2019","unstructured":"Fujita K, Nonomura N. Role of androgen receptor in prostate cancer: A review. World J Mens Health. 2019;37(3):288\u201395.","journal-title":"World J Mens Health"},{"issue":"21","key":"15792_CR18","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.3390\/cancers13215417","volume":"13","author":"A Jacob","year":"2021","unstructured":"Jacob A, Raj R, Allison DB, Myint ZW. Androgen receptor signaling in prostate cancer and therapeutic strategies. Cancers (Basel). 2021;13(21):5417.","journal-title":"Cancers (Basel)"},{"key":"15792_CR19","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ijbiomac.2022.07.058","volume":"218","author":"A Khan","year":"2022","unstructured":"Khan A, Mao Y, Tahreem S, Wei DQ, Wang Y. Structural and molecular insights into the mechanism of resistance to enzalutamide by the clinical mutants in androgen receptor (AR) in castration-resistant prostate cancer (CRPC) patients. Int J Biol Macromol. 2022;218:856\u201365.","journal-title":"Int J Biol Macromol"},{"key":"15792_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13059-015-0864-1","volume":"17","author":"N Lallous","year":"2016","unstructured":"Lallous N, Volik SV, Awrey S, Leblanc E, Tse R, Murillo J, et al. Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients. Genome Biol. 2016;17:10.","journal-title":"Genome Biol"},{"issue":"11","key":"15792_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-018-0085-0","volume":"15","author":"A Paschalis","year":"2018","unstructured":"Paschalis A, Sharp A, Welti JC, Neeb A, Raj GV, Luo J, et al. Alternative splicing in prostate cancer. Nat Rev Clin Oncol. 2018;15(11):663\u201375.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"15792_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrurol.2015.13","volume":"12","author":"J Lu","year":"2015","unstructured":"Lu J, Der Steen T, Van, Tindall DJ. Are androgen receptor variants a substitute for the full-length receptor? Nat Rev Urol. 2015;12(3):137\u201344.","journal-title":"Nat Rev Urol"},{"issue":"6","key":"15792_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1042\/EBC20200167","volume":"65","author":"Y Arao","year":"2021","unstructured":"Arao Y, Korach KS. The physiological role of estrogen receptor functional domains. Essays Biochem. 2021;65(6):867\u201375.","journal-title":"Essays Biochem"},{"issue":"1","key":"15792_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/aps.2014.18","volume":"36","author":"ME Tan","year":"2015","unstructured":"Tan ME, Li J, Xu HE, Melcher K, Yong EL. Androgen receptor: Structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin. 2015;36(1):3\u201323.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"15792_CR25","first-page":"3","volume":"37","author":"RA Davey","year":"2016","unstructured":"Davey RA, Grossmann M. Androgen Receptor Structure, Function and Biology: From Bench to Bedside. Clin Biochem Rev. 2016;37(1):3\u201315.","journal-title":"Clin Biochem Rev"},{"issue":"11","key":"15792_CR26","doi-asserted-by":"publisher","first-page":"eade2175","DOI":"10.1126\/sciadv.ade2175","volume":"9","author":"A Alegre-Mart\u00ed","year":"2023","unstructured":"Alegre-Mart\u00ed A, Jim\u00e9nez-Panizo A, Mart\u00ednez-T\u00e9bar A, Poulard C, N\u00faria Peralta-Moreno M, Abella M, et al. A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance. Sci Adv. 2023;9(11):eade2175.","journal-title":"Sci Adv"},{"issue":"11","key":"15792_CR27","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.molcel.2022.03.035","volume":"82","author":"EV Wasmuth","year":"2022","unstructured":"Wasmuth EV, Broeck A, Vanden, LaClair JR, Hoover EA, Lawrence KE, Paknejad N, et al. Allosteric interactions prime androgen receptor dimerization and activation. Mol Cell. 2022;82(11):2021\u2013e20315.","journal-title":"Mol Cell"},{"issue":"19","key":"15792_CR28","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1016\/j.molcel.2023.08.027","volume":"83","author":"L Chen","year":"2023","unstructured":"Chen L, Zhang Z, Han Q, Maity BK, Rodrigues L, Zboril E, et al. Hormone-induced enhancer assembly requires an optimal level of hormone receptor multivalent interactions. Mol Cell. 2023;83(19):3438\u2013e345612.","journal-title":"Mol Cell"},{"issue":"7","key":"15792_CR29","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.21037\/tcr-21-372","volume":"10","author":"W Liu","year":"2021","unstructured":"Liu W, Zhu Y, Ye L, Zhu Y, Wang Y. Comparison of tumor angiogenesis in subcutaneous and orthotopic LNCaP mouse models using contrast-enhanced ultrasound imaging. Transl Cancer Res. 2021;10(7):3268\u201377.","journal-title":"Transl Cancer Res"},{"issue":"4","key":"15792_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41585-021-00438-4","volume":"18","author":"KT Schmidt","year":"2021","unstructured":"Schmidt KT, Huitema ADR, Chau CH, Figg WD. Resistance to second-generation androgen receptor antagonists in prostate cancer. Nat Rev Urol. 2021;18(4):209\u201326.","journal-title":"Nat Rev Urol"},{"issue":"7","key":"15792_CR31","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41388-020-01598-0","volume":"40","author":"N Formaggio","year":"2021","unstructured":"Formaggio N, Rubin MA, Theurillat JP. Loss and revival of androgen receptor signaling in advanced prostate cancer. Oncogene. 2021;40(7):1205\u201316.","journal-title":"Oncogene"},{"key":"15792_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-physiol-030212-183656","volume":"75","author":"T Matsumoto","year":"2013","unstructured":"Matsumoto T, Sakari M, Okada M, Yokoyama A, Takahashi S, Kouzmenko A, et al. The androgen receptor in health and disease. Annu Rev Physiol. 2013;75:201\u201324.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"15792_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuron.2017.07.029","volume":"96","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Taylor JP. Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases. Neuron. 2017;96(2):285\u201397.","journal-title":"Neuron"},{"issue":"5","key":"15792_CR34","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cell.2018.07.015","volume":"174","author":"V Rodriguez-Bravo","year":"2018","unstructured":"Rodriguez-Bravo V, Pippa R, Song WM, Carceles-Cordon M, Dominguez-Andres A, Fujiwara N, et al. Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import. Cell. 2018;174(5):1200\u2013e121520.","journal-title":"Cell"},{"issue":"3","key":"15792_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41571-020-00442-4","volume":"18","author":"AS Azmi","year":"2021","unstructured":"Azmi AS, Uddin MH, Mohammad RM. The nuclear export protein XPO1 \u2014 from biology to targeted therapy. Nat Rev Clin Oncol. 2021;18(3):152\u201369.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"15792_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41375-021-01483-z","volume":"36","author":"SK Balasubramanian","year":"2022","unstructured":"Balasubramanian SK, Azmi AS, Maciejewski J. Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms. Leukemia. 2022;36(3):601\u201312.","journal-title":"Leukemia"},{"issue":"1","key":"15792_CR37","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s42003-024-07237-8","volume":"7","author":"T Vercruysse","year":"2024","unstructured":"Vercruysse T, Vanstreels E, Jacquemyn M, Boland S, Kilonda A, Allasia S, et al. Ibetazol, a novel inhibitor of importin \u03b21-mediated nuclear import. Commun Biol. 2024;7(1):1560.","journal-title":"Commun Biol"},{"issue":"4","key":"15792_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.cellsig.2015.01.013","volume":"27","author":"W Yan","year":"2015","unstructured":"Yan W, Li R, He J, Du J, Hou J. Importin \u03b21 mediates nuclear factor-\u03baB signal transduction into the nuclei of myeloma cells and affects their proliferation and apoptosis. Cell Signal. 2015;27(4):851\u20139.","journal-title":"Cell Signal"},{"issue":"4","key":"15792_CR39","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1158\/1535-7163.MCT-15-0052","volume":"15","author":"PJ Van Der Watt","year":"2016","unstructured":"Van Der Watt PJ, Chi A, Stelma T, Stowell C, Strydom E, Carden S, et al. Targeting the nuclear import receptor Kpn\u03b21 as an anticancer therapeutic. Mol Cancer Ther. 2016;15(4):560\u201373.","journal-title":"Mol Cancer Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15792-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:53:21Z","timestamp":1774972401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15792-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15792"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15792-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"428"}}